Abstract
Abstract
Ethosomes are most commonly used vesicular delivery system compared to other lipidic vesicles due to its ethanolic content. Thymoquinone (TQ), the main biologically active complex of Black Cumin seed, has established anticancer activities in several tumors. In this work, the preparation of ethosome for TQ encapsulation by response surface method (RSM) was developed. Central composite design (CCD) was used to optimize three effective parameters involved in ethosome structure including phospholipid, cholesterol and ethanol concentration and the combined effects of them, as well. The obtained optimum values for the variables were phospholipid 5% (W/W), ethanol 45% (V/V) and cholesterol 1.5% (W/W) which were validated by experimental assay. The ethosomal formulation was more characterized for vesicle shape, size, zeta potential and entrapment efficiency percentage. The result showed an efficiency of 99% for drug entrapment with average vesicle size and zeta potential of 20 ± 1 nm and − 63 ± 2 mv, respectively. A quadratic model with a high adequacy (R2) for size and zeta potential of 0.9319 and 0.9338, respectively, was resulted from RSM and experimental assay. Thymoquinone (TQ) encapsulated in optimized ethosome. Also, cellular toxicity and release test was done. The toxicity and release curves were obtained and the cytotoxic activity of the ethosomic TQ against MCF-7 cell lines was greater than free TQ. IC50 values of free TQ, ethosomic TQ, were found to be 1.10 µg/ml, 0.95 µg/ml, respectively. The generated model suggests a new approach to prediction and experimental lipidic carriers.
Graphic abstract
Central composite design (CCD) was used to optimize three effective parameters involved in ethosome structure including phospholipid, cholesterol and ethanol concentration and the combined effects of them, as well. The ethosomal formulation was more characterized for vesicle shape, size, zeta potential and entrapment efficiency percentage. Also, cellular toxicity and release test was done. The toxicity and release curves were obtained and the cytotoxic activity of the ethosomic TQ against MCF-7 cell lines was greater than free TQ.
Funder
University of Tehran, University of Tehran science and technology Park
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Zhang, Y.T., Shen, L.-N., Zhao, J.-H., Feng, N.-P.: Evaluation of psoralen ethosomes for topical delivery in rats by using in vivo microdialysis. Int. J. Nanomed. 9, 669–678 (2014)
2. Tyagi, L.K., Kumar, S., Maurya, S.S., Kori, M.L.: Ethosomes: novel vesicular carrier for enhanced transdermal drug delivery system. Bull. Pharm. Res. 3(1), 6–13 (2013)
3. Nandure, H.P., Puranik, P., Giram, P., Lone, V.: Ethosome: A Novel Drug Carrier. Int. J. Pharm. Res. Allied Sci. 2(3), 2277–3657 (2013)
4. Pathan, I.B., Jaware, B.P., Shelke, S., Ambekar, W.: Curcumin loaded ethosomes for transdermal application: Formulation, optimization, in-vitro and in-vivo study. J. Drug Del. Sci. Tech. 44, 49–57 (2018)
5. Jangdey, M.S., Gupta, A., Saraf, S., Saraf, S.: Development and optimization of apigenin-loaded transfersomal system for skin cancer delivery: in vitro evaluation. Artif. Cells Nanomed. B. 45(7), 1452–1462 (2017)
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献